Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.

Biochimica et biophysica acta - 1 Dec 2009

Rosenbaum Anton I, Rujoi Madalina, Huang Amy Y, Du Hong, Grabowski Gregory A, Maxfield Frederick R

Abstract excerpt

Niemann-Pick C disease (NPC) is a lysosomal storage disorder causing abnormal accumulation of unesterified free cholesterol in lysosomal storage organelles. High content phenotypic microscopy chemical screens in both human and hamster NPC-deficient cells have identified several compounds that par...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cricetulus
Share to Drug Evaluation, Preclinical
Share to Lipoprotein Lipase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Niemann-Pick Disease, Type C

Share to Small Molecule Libraries

Share to Sterol Esterase

Share to Sterols

Source

Open in PubMed Open full text

Identifiers

PMID: 19699313
DOI: 10.1016/j.bbalip.2009.08.005
PMCID: PMC2783675

Genes

NPC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19699313-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.PMID 19699313Read ↗

Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells.Semantic proximity Read ↗

Identification of a pharmaceutical compound that partially corrects the Niemann-Pick C phenotype in cultured cells.Semantic proximity Read ↗

Cholesterol pathways affected by small molecules that decrease sterol levels in Niemann-Pick type C mutant cells.Semantic proximity Read ↗

Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.Semantic proximity Read ↗

A phenotypic compound screening assay for lysosomal storage diseases.Semantic proximity Read ↗

Niemann-Pick Type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage.Semantic proximity Read ↗

Inhibition of acid ceramidase as a therapeutic strategy for Niemann-Pick C diseaseSemantic proximity Read ↗

Screening of small molecule chemical library identifies leads that reduce cholesterol accumulation in human NPC1 fibroblastsSemantic proximity Read ↗

Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.Semantic proximity Read ↗

Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapiesSemantic proximity Read ↗

Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds.Semantic proximity Read ↗

Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.